Body fat distribution and cardiovascular risk: A tale of 2 sites

Archives of Internal Medicine

Volumn 168, Issue 15, 2008, Pages 1607-1608

  Landsberg, Lewis ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; EDITORIAL; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; PHENOTYPE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASES; HUMANS; INSULIN RESISTANCE; OBESITY; RISK ASSESSMENT; WAIST-HIP RATIO;

EID: 49449111892     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.168.15.1607     Document Type: Editorial

References (26)

1. Stefan N, Kantartzis K, Machann J, et al. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168(15):1609-1616.
2. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population: (NHANES 1999-2004). Arch Intern Med. 2008;168(15):1617-1624.
3. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr. 1956;4(1):20-34.
4. Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjöström L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed). 1984;289(6454):1257-1261.
5. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed). 1984;288(6428):1401-1404.
6. Kissebah AH, Vydelingum N, Murray R, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab. 1982;54(2):254-260.
7. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women: importance of regional adipose tissue distribution. J Clin Invest. 1983;72(3):1150-1162.
8. Kalkhoff RK, Hartz AH, Rupley D, Kissebah AH, Kelber S. Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. J Lab Clin Med. 1983;102(4):621-627.
9. Cassano PA, Segal MR, Vokonas PS, Weiss ST. Body fat distribution, blood pressure, and hypertension: a prospective cohort study of men in the Normative Aging Study. Ann Epidemiol. 1990;1(1):33-48.
10. Landsberg L. The metabolic syndrome: diabetes, obesity and hypertension. In: Birkenhager WH, Zanchetti A, Robertson JIS, eds. Hypertension in the Twentieth Century: Concepts and Achievements. Amsterdam, the Netherlands: Elsevier Science Publishers; 2004:245-261. Handbook of Hypertension; vol 22.
11. Després JP. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-887.
12. Zavaroni I, Mazza S, Dall'Aglio E, Gasparini P, Passeri M, Reaven GM. Prevalence of hyperinsulinaemia in patients with high blood pressure. J Intern Med. 1992;231(3):235-240.
13. Reaven GM. Insulin resistance: a chicken that has come to roost. Ann N Y Acad Sci. 1999;892:45-57.
14. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens. 2001;19(3, pt 2):523-528.
15. Modan M, Halkin H, Almog S, et al. Hyperinsulinemia: a link between hypertension obesity and glucose intolerance. J Clin Invest. 1985;75(3):809-817.
16. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317(6):350-357.
17. Ward KD, Sparrow D, Vokonas PS, Willett WC, Landsberg L, Weiss ST. The relationships of abdominal obesity, hyperinsulinemia and saturated fat intake to serum lipid levels: the Normative Aging Study. Int J Obes Relat Metab Disord. 1994;18(3):137-144.
18. Ward KD, Sparrow D, Landsberg L, Young JB, Vokonas PS, Weiss ST. The relationship of epinephrine excretion to serum lipid levels: the Normative Aging Study. Metabolism. 1994;43(4):509-513.
19. Smith U. Regional difference in adipocyte metabolism and possible consequences in vivo. In: Hirsch J, Van Itallie TB, eds. Recent Advances in Obesity Research IV, Proceedings of the 4th International Congress on Obesity. London, England: John Libbey; 1983:33-36.
20. Balaban YH, Sumer H, Simsek H, Us D, Tatar G. Metabolic syndrome, non-alcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF). Ann Hepatol. 2006;5(2):109-114.
21. Landsberg L. The sympatho-adrenal system in the metabolic syndrome. In: Hansen BC, Bray GA, eds. The Metabolic Syndrome: Epidemiology, Clinical Treatment, and Underlying Mechanisms. Totowa, NJ: Humana Press; 2008:85-104.
22. Bujalska IJ, Kumar S, Stewart PM. Does central obesity reflect "Cushing's disease of the omentum"? Lancet. 1997;349(9060):1210-1213.
23. Stewart PM. Tissue-specific Cushing's syndrome, 11β-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action. Eur J Endocrinol. 2003;149(3):163-168.
24. Turek FW, Joshu C, Kohsaka A, et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science. 2005;308(5724):1043-1045.
25. Spiegel K, Leproult R, L'hermite-Balériaux M, Copinschi G, Penev PD, Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab. 2004;89(11):5762-5771.
26. Landsberg L. Insulin resistance and the metabolic syndrome. Diabetologia. 2005;48(7):1244-1246.